📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells. (2020)

First Author: Scurr MJ

Attributed to: Utilising proteomics to develop anti-HCMV immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-19-3087

PubMed Identifier: 32122920

Publication URI: http://europepmc.org/abstract/MED/32122920

Type: Journal Article/Review

Volume: 26

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 13

ISSN: 1078-0432